These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21554217)

  • 21. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.
    Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA
    Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of antibiotics in obese and critical care patients].
    Stahlmann R; Lode H
    Dtsch Med Wochenschr; 2015 Feb; 140(4):271-6. PubMed ID: 25704524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of linezolid in critically ill patients.
    Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
    Heffernan AJ; Sime FB; Taccone FS; Roberts JA
    Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosing guidance for intravenous colistin in critically-ill patients.
    Nation RL; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Forrest A; Paterson DL; Li J; Silveira FP
    Clin Infect Dis; 2017 Mar; 64(5):565-571. PubMed ID: 28011614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
    Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL;
    Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis.
    Mei JP; Ali-Moghaddam A; Mueller BA
    Int J Clin Pharm; 2016 Feb; 38(1):127-34. PubMed ID: 26499505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of antibiotic pharmacokinetic principles in the critically ill.
    Udy AA; Roberts JA; Lipman J
    Intensive Care Med; 2013 Dec; 39(12):2070-82. PubMed ID: 24045886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Augmented renal clearance of antibiotics may lead to inadequate dosings for patients with sepsis].
    Moser C; Hartvig T; Schierbeck J; Høiby N
    Ugeskr Laeger; 2016 Mar; 178(11):V05150426. PubMed ID: 27032308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Critical Illness Change Levofloxacin Pharmacokinetics?
    Roberts JA; Cotta MO; Cojutti P; Lugano M; Della Rocca G; Pea F
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1459-63. PubMed ID: 26666946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.
    Kielstein JT; Burkhardt O
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2015-9. PubMed ID: 21554216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmented renal clearance: implications for antibacterial dosing in the critically ill.
    Udy AA; Roberts JA; Boots RJ; Paterson DL; Lipman J
    Clin Pharmacokinet; 2010; 49(1):1-16. PubMed ID: 20000886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
    Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right dose, right now: using big data to optimize antibiotic dosing in the critically ill.
    Elbers PW; Girbes A; Malbrain ML; Bosman R
    Anaesthesiol Intensive Ther; 2015; 47(5):457-63. PubMed ID: 26459228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of dosing regimens and dosing in special populations.
    Sime FB; Roberts MS; Roberts JA
    Clin Microbiol Infect; 2015 Oct; 21(10):886-93. PubMed ID: 25980350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.